Ascendiant Capital Markets, LLC

What does Ascendiant Capital Markets, LLC do?

Ascendiant Capital Markets, LLC describes itself as a full-service boutique investment bank providing corporate finance, M&A advisory, equity research, institutional sales, and market making and trading services. Its public office is listed at 110 Front Street, Suite 300, Jupiter, Florida 33477.

The firm states that it generally specializes in the lower middle market and represents clients with revenues of $10 million to $200 million. It also states that it has led or participated in over $3+ billion in transactions.[1][2][3]

Ascendiant provides M&A advisory services in both sell-side and buy-side capacities. Its corporate finance practice provides equity capital, debt financing, strategic guidance, and advisory services to public and private companies.

The firm’s market-making and trading division uses firm capital to provide liquidity and offers at-the-market offerings, corporate buybacks, institutional orders, block trades, and market making. Its public transaction materials also identify placement-agent, sales-agent, financial-advisor, and M&A-advisor roles.[3][4][5][6]

Owners comparing advisory firms can also review Auxo’s M&A advisor vs. business broker vs. investment bank comparison, advisor-selection guide, and sell-side advisor evaluation framework.

What should a business owner evaluate before hiring Ascendiant Capital Markets, LLC?

For an owner considering a sale, Ascendiant publicly presents sell-side M&A capabilities, a lower-middle-market focus with stated client revenues of $10 million to $200 million, and more than 300 completed M&A transactions. Its disclosed examples include dental, technology, and industrial businesses.

Because the firm also conducts financing, equity research, institutional sales, market making, and trading activities, an owner should clarify the proposed engagement team, buyer outreach plan, conflicts-management process, fee terms, and whether any financing, placement-agent, or other capital-markets role would accompany the M&A mandate.[3][5][6][8]

What size transactions and clients does Ascendiant Capital Markets, LLC focus on?

Ascendiant’s equity research team covers healthcare, including biotech, life sciences, and medical devices, technology, energy, consumer, media and entertainment, and internet sectors. The firm states that its investment banking division has initiated, negotiated, and completed over 300 M&A transactions across a wide range of industry sectors.[1][3]

Recent financing examples identified in the official transaction archive include Aether Holdings, Inc.’s $1,620,000 private placement in August 2026, for which Ascendiant was sole placement agent; Air T, Inc.’s $8,000,000 at-the-market offering in July 2026, for which Ascendiant was sole sales agent; and Intrusion Inc.’s $3,230,000 private placement in April 2026, for which Ascendiant was financial advisor.

Selected M&A examples include Royal Dental, identified as acquired by Brident Dental & Orthodontics in September 2022 with Ascendiant as sole M&A advisor; Technology Assessment & Transfer, identified as acquired in July 2022 with Ascendiant as sole M&A advisor; and Pinnacle Precision Sheet Metal Corporation, identified as acquired by The Partner Companies in June 2022 with Ascendiant as sole M&A advisor.[6]

The firm’s public activities include sell-side and buy-side M&A advisory, equity and debt financing, private placements, at-the-market offerings, and other capital-markets services. The transaction archive shows Ascendiant acting as sole placement agent, sole sales agent, financial advisor, and sole M&A advisor in selected assignments.[3][4][5][6]

What does Ascendiant Capital Markets, LLC publicly disclose about fees, process and engagement terms?

The cited official contact page identifies the Jupiter, Florida office but does not state a geographic mandate or exclusive regional focus.

The cited official M&A page does not state universal EBITDA or enterprise-value thresholds for the clients it represents. That page also does not publish standardized advisory fee percentages, minimum fees, termination fees, tail provisions, or expense provisions.

The cited official transaction archive lists selected M&A transaction parties and dates but does not publish transaction consideration or enterprise value for those listed M&A examples.[2][3][6]

FINRA’s firm report identifies Ascendiant Capital Markets, LLC as a broker-dealer registered with the SEC and one self-regulatory organization, with CRD #152912 and SEC #8-68487. The report states that its SEC and FINRA registrations became effective February 28, 2011.

FINRA identifies Ascendiant Capital Partners, LLC as the direct parent and sole member. Ascendiant Capital Markets introduces securities transactions on a fully disclosed basis to Axos Clearing LLC. A 2025 SEC-filed public audit describes the firm as a single-member Nevada LLC and a wholly owned subsidiary of Ascendiant Capital Partners, LLC.[7][8]

Ascendiant states that members of its investment banking division average over twenty-five years of experience. It also states that the firm has supported companies and ideas for 24+ years.

The cited public materials identify sell-side and buy-side advisory capabilities but do not set out a standardized engagement process. An owner evaluating a mandate should request detail on team composition, buyer outreach, conflicts management, fee terms, and any additional capital-markets role.[3][4][5]

Questions to ask before hiring Ascendiant Capital Markets, LLC

Related Auxo guidance

Use these resources to evaluate role, structure, economics and process rather than relying on a directory profile alone.